Theratechnologies (THTX)
(Delayed Data from NSDQ)
$1.29 USD
+0.03 (2.38%)
Updated May 15, 2024 10:35 AM ET
2-Buy of 5 2
B Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Theratechnologies Inc. [THTX]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Theratechnologies Inc.
Industry: Medical - Biomedical and Genetics
Company: Theratechnologies Inc.
Industry: Medical - Biomedical and Genetics
Final Program for Our Fourth Annual Virtual NASH Investor Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Theratechnologies Inc.
Industry: Medical - Biomedical and Genetics
Stable Q220 Egrifta/Trogarzo Sales Despite Current Climate. Clinical Activities in Oncology and NASH on the Horizon - BUY
Provider: Echelon Welath Partners
Analyst: LOE D
|